DOCS · Doximity, Inc.

The resignation of Doximity’s Chief Financial Officer represents a high-materiality executive transition, given the CFO’s central role in financial reporting, capital allocation, investor communications, and SEC compliance. Anna Bryson’s departure follows a documented medical leave beginning February 5, 2026, and culminates in a formal resignation accepted on April 13, 2026 — less than ten weeks after the leave commenced. The Board responded by appointing Siddharth Sitaram, the incumbent Chief Accounting Officer, to dual interim roles effective February 3, 2026 — suggesting internal readiness but also highlighting the absence of a pre-identified permanent successor. Notably, the filing discloses no details regarding Sitaram’s interim compensation, reporting structure, or duration beyond the statement that he will serve “until a new Chief Financial Officer is appointed.” The Company explicitly identifies CFO recruitment success and transition-related disruption as top-tier risk factors, underscoring governance and operational sensitivities. With no timeline, search process details, or succession plan disclosed — and the next update deferred to an unspecified future earnings call — investors face near-term uncertainty regarding financial leadership stability, audit oversight continuity, and strategic execution capacity.